WP1. Project management and communication

WP2. Pre-clinical development of BAL30072

WP3. Clinical development of BAL30072 for use in patients with Cystic Fibrosis (Clinical Studies)

WP4. Phase II Clinical study of efficacy and safety of tobramycin in BE patients

WP5. Development of an EU bronchiectasis registry

WP6. Novel outcome measures for clinical trials

WP7. Pre-clinical development of Murepavadin (POL7080) as an inhalation therapy

WP8. Clinical development of Murepavadin (POL7080) for use in patients with Cystic Fibrosis (clinical studies)

WP9. Clinical development of ALX-009 for use in patients with cystic fibrosis and bronchiectasis

WP10. Clinical development of QBW251 for use in patients with bronchiectasis

WP11. Novel outcome measures for clinical trials and analysis of EMBARC registry data.